3,3,3-TRIFLUORO-2,2-DIMETHYLPROPAN-1-OL, 95.0%, 1g

2-Methyl-4-morpholin-4-yl-benzaldehyde, 100mg

2-(Perfluorohexyl)ethyl acrylate, 97.0%, 10g

3-(2,4,6-trimethoxyphenyl)propanoic acid, 95.0%, 2.5g

D-Lysine, N6-(aminocarbonyl)-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 97%, 5g

GC capillary column ROTI®Cap-5 MS Ultra, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

1-N-Boc-3-Pyrrolidinone, 99.0%, 1g

2,6-Dichlorobenzylalcohol, 97.0%, 10g

6-Bromo-1,2,4-triazin-3-amine, 95.0%, 1g

2-chloro-N-(5-ethyl-1,3,4-thiadiazol-2-yl)propanamide, 95.0%, 5g

2-Bromo-4-methyl-1H-imidazole, 95.0%, 250mg

2-Chloro-5,6-dihydro-7H-cyclopenta[b]pyridin-7-one, 97%, 500mg

1-(6-(2-Fluorophenoxy)pyridin-3-yl)ethanone, 95%, 1g